Effects of Blood Glutamate Scavenging on Cortical Evoked Potentials

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2010 Jul 8

PMID 20607387

Citations 5

Authors

David Nagy

Levente Knapp

Mate Marosi

Tamas Farkas

Zsolt Kis

Laszlo Vecsei

Vivian I Teichberg

Jozsef Toldi

Affiliations

Soon will be listed here.

Abstract

It is well known that traumatic or ischemic brain injury is followed by acute excitotoxicity caused by the presence of abnormally high glutamate (Glu) in brain fluids. It has recently been demonstrated that excess Glu can be eliminated from brain into blood following the intravenous administration of oxaloacetate (OxAc), which, by scavenging blood Glu, induces an enhanced and neuroprotective brain-to-blood Glu efflux. In this study, we subjected rats to intravenous OxAc administration (i.v., 12.5, 25, and 50 mg/kg, respectively), and studied its effects on somatosensory evoked cortical potentials (EPs). Against our expectation, the amplitudes of EPs did not decrease but increased in a dose- and time-dependent manner after OxAc administration. Similar effects were observed when blood Glu scavenging was enhanced by combining OxAc (12.5 mg/kgbw) with recombinant glutamate-oxaloacetate transaminase (GOT, 0.14 nmol/100 g rat). On the basis of these results, we suggest that the changes of amplitudes of the EPs involve not only a glutamatergic but also the weakening of a GABAergic component. We cannot rule out the possibility that OxAc penetrates into the brain and improves mitochondrial functions.

Citing Articles

Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.

Brotfain E, Kutz R, Grinshpun J, Gruenbaum B, Gruenbaum S, Frenkel A Neurotox Res. 2017; 33(2):300-308.

PMID: 28836163 PMC: 5767130. DOI: 10.1007/s12640-017-9791-0.

Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.

Knapp L, Gellert L, Kocsis K, Kis Z, Farkas T, Vecsei L Cell Mol Neurobiol. 2014; 35(1):17-22.

PMID: 24807461 PMC: 11486343. DOI: 10.1007/s10571-014-0064-7.

Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?.

Dantzer R, Walker A J Neural Transm (Vienna). 2014; 121(8):925-32.

PMID: 24633997 PMC: 4134384. DOI: 10.1007/s00702-014-1187-1.

Glutamate as a neurotransmitter in the healthy brain.

Zhou Y, Danbolt N J Neural Transm (Vienna). 2014; 121(8):799-817.

PMID: 24578174 PMC: 4133642. DOI: 10.1007/s00702-014-1180-8.

The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.

Majlath Z, Toldi J, Vecsei L J Neural Transm (Vienna). 2013; 121(8):881-9.

PMID: 24346138 DOI: 10.1007/s00702-013-1135-5.

References

Sas K, Robotka H, Toldi J, Vecsei L . Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci. 2007; 257(1-2):221-39. DOI: 10.1016/j.jns.2007.01.033. View

Holmes O, Short A . Interaction of cortical evoked potentials in the rat. J Physiol. 1970; 209(2):433-52. PMC: 1395743. DOI: 10.1113/jphysiol.1970.sp009173. View

Teichberg V, Cohen-Kashi-Malina K, Cooper I, Zlotnik A . Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience. 2008; 158(1):301-8. DOI: 10.1016/j.neuroscience.2008.02.075. View

Farkas T, Kis Z, Toldi J, Wolff J . Activation of the primary motor cortex by somatosensory stimulation in adult rats is mediated mainly by associational connections from the somatosensory cortex. Neuroscience. 1999; 90(2):353-61. DOI: 10.1016/s0306-4522(98)00451-5. View

Suzuki M, Kudo A, Sugawara A, Yoshida K, Kubo Y, Suzuki T . Amino acid concentrations in the blood of the jugular vein and peripheral artery after traumatic brain injury: decreased release of glutamate into the jugular vein in the early phase. J Neurotrauma. 2002; 19(2):285-92. DOI: 10.1089/08977150252807027. View

Marosi M, Fuzik J, Nagy D, Rakos G, Kis Z, Vecsei L . Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol. 2009; 604(1-3):51-7. DOI: 10.1016/j.ejphar.2008.12.022. View

Foster A, Kemp J . Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2005; 6(1):7-17. DOI: 10.1016/j.coph.2005.11.005. View

Farazifard R, Wu S . Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus. Brain Res. 2010; 1325:28-40. DOI: 10.1016/j.brainres.2010.02.021. View

Belan P, Kostyuk P . Glutamate-receptor-induced modulation of GABAergic synaptic transmission in the hippocampus. Pflugers Arch. 2002; 444(1-2):26-37. DOI: 10.1007/s00424-002-0783-3. View

10.

Toldi J, Farkas T, Perge J, Wolff J . Facial nerve injury produces a latent somatosensory input through recruitment of the motor cortex in the rat. Neuroreport. 1999; 10(10):2143-7. DOI: 10.1097/00001756-199907130-00027. View

11.

Lur G, Rakos G, Juhasz-Vedres G, Farkas T, Kis Z, Toldi J . Effects of dehydroepiandrosterone sulfate on the evoked cortical activity of controls and of brain-injured rats. Cell Mol Neurobiol. 2006; 26(7-8):1505-19. PMC: 11520763. DOI: 10.1007/s10571-006-9073-5. View

12.

Engelman H, MacDermott A . Presynaptic ionotropic receptors and control of transmitter release. Nat Rev Neurosci. 2004; 5(2):135-45. DOI: 10.1038/nrn1297. View

13.

Zlotnik A, Gurevich B, Cherniavsky E, Tkachov S, Matuzani-Ruban A, Leon A . The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res. 2007; 33(6):1044-50. DOI: 10.1007/s11064-007-9548-x. View

14.

Liu S . Biphasic modulation of GABA release from stellate cells by glutamatergic receptor subtypes. J Neurophysiol. 2007; 98(1):550-6. DOI: 10.1152/jn.00352.2007. View

15.

Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L . Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol. 2009; 29(6-7):827-35. PMC: 11506091. DOI: 10.1007/s10571-009-9364-8. View

16.

Vesce S, Rossi D, Brambilla L, Volterra A . Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol. 2007; 82:57-71. DOI: 10.1016/S0074-7742(07)82003-4. View

17.

Castillo J, Davalos A, Naveiro J, Noya M . Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996; 27(6):1060-5. DOI: 10.1161/01.str.27.6.1060. View

18.

Gottlieb M, Wang Y, Teichberg V . Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem. 2003; 87(1):119-26. DOI: 10.1046/j.1471-4159.2003.01972.x. View

19.

Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg V . Brain neuroprotection by scavenging blood glutamate. Exp Neurol. 2006; 203(1):213-20. DOI: 10.1016/j.expneurol.2006.08.021. View

20.

Stoffel M, Plesnila N, Eriskat J, Furst M, Baethmann A . Release of excitatory amino acids in the penumbra of a focal cortical necrosis. J Neurotrauma. 2002; 19(4):467-77. DOI: 10.1089/08977150252932415. View